• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms.尿微生物群在良性前列腺增生/下尿路症状中的潜在作用
Diagnostics (Basel). 2022 Aug 1;12(8):1862. doi: 10.3390/diagnostics12081862.
2
The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms.男性生殖泌尿系统疾病中的尿道微生物群:聚焦于良性前列腺增生和下尿路症状
Int Neurourol J. 2021 Mar;25(1):3-11. doi: 10.5213/inj.2040174.087. Epub 2021 Jan 19.
3
The urinary and prostatic microbiome in non-neurogenic male LUTS/BPH: A systematic review.非神经源性男性下尿路症状/良性前列腺增生中的泌尿和前列腺微生物群:一项系统综述。
Neurourol Urodyn. 2024 Nov;43(8):1938-1947. doi: 10.1002/nau.25530. Epub 2024 Jun 27.
4
Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms.男性膀胱微生物群与下尿路症状相关。
Eur Urol Focus. 2020 Mar 15;6(2):376-382. doi: 10.1016/j.euf.2018.08.001. Epub 2018 Aug 22.
5
Prostate diseases and microbiome in the prostate, gut, and urine.前列腺疾病以及前列腺、肠道和尿液中的微生物群。
Prostate Int. 2022 Jun;10(2):96-107. doi: 10.1016/j.prnil.2022.03.004. Epub 2022 Mar 29.
6
The impact of urine microbiota in patients with lower urinary tract symptoms.尿液微生物组对下尿路症状患者的影响。
Ann Clin Microbiol Antimicrob. 2021 Apr 15;20(1):23. doi: 10.1186/s12941-021-00428-9.
7
BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in men.体重指数(BMI)和良性前列腺增生(BPH)与男性的泌尿微生物群多样性及下尿路症状相关。
bioRxiv. 2023 Dec 15:2023.12.14.571758. doi: 10.1101/2023.12.14.571758.
8
Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.前列腺体积是否可预测有轻度至无当前症状的男性中出现下尿路症状的发展?来自 REDUCE 试验的结果。
Eur Urol. 2016 May;69(5):885-91. doi: 10.1016/j.eururo.2015.12.002. Epub 2015 Dec 24.
9
Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.良性前列腺增生男性尿脑源性神经营养因子增加与下尿路症状的关联
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):531-535. doi: 10.1007/s11596-017-1768-y. Epub 2017 Aug 8.
10
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.

引用本文的文献

1
Body mass index and benign prostatic hyperplasia correlate with urinary microbiome diversity and lower urinary tract symptoms in men.体重指数和良性前列腺增生与男性尿液微生物群多样性及下尿路症状相关。
Commun Med (Lond). 2025 May 7;5(1):159. doi: 10.1038/s43856-025-00866-y.
2
NK Cell-Microbiota Interaction Biomarker Strategy: Advancing Prostate Cancer Management.自然杀伤细胞-微生物群相互作用生物标志物策略:推动前列腺癌管理
Biomolecules. 2025 Feb 13;15(2):273. doi: 10.3390/biom15020273.
3
Lactobacillus-Polydopamine System for Targeted Drug Delivery in Overactive Bladder: Evidence from Bladder Cell Spheroids, Rat Models, and Urinary Microbiome Profiling.乳杆菌-聚多巴胺体系用于膀胱过度活动症的靶向药物递送:来自膀胱细胞球体、大鼠模型和尿液微生物组分析的证据。
Int J Nanomedicine. 2024 Aug 15;19:8353-8371. doi: 10.2147/IJN.S465745. eCollection 2024.
4
Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities.微生物组与前列腺癌:新出现的诊断和治疗机遇
Pharmaceuticals (Basel). 2024 Jan 13;17(1):112. doi: 10.3390/ph17010112.
5
BMI and BPH correlate with urinary microbiome diversity and lower urinary tract symptoms in men.体重指数(BMI)和良性前列腺增生(BPH)与男性的泌尿微生物群多样性及下尿路症状相关。
bioRxiv. 2023 Dec 15:2023.12.14.571758. doi: 10.1101/2023.12.14.571758.
6
Urinary Tract Infection and Microbiome.尿路感染与微生物群
Diagnostics (Basel). 2023 May 31;13(11):1921. doi: 10.3390/diagnostics13111921.
7
Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome.良性前列腺增生概述:营养保健品中的膳食多酚、维生素和植物化学物质对前列腺微生物组的影响可缓解症状。
Int J Mol Sci. 2023 Mar 13;24(6):5486. doi: 10.3390/ijms24065486.
8
Possibilities and limitations of using low biomass samples for urologic disease and microbiome research.使用低生物量样本进行泌尿系统疾病和微生物组研究的可能性与局限性。
Prostate Int. 2022 Dec;10(4):169-180. doi: 10.1016/j.prnil.2022.10.001. Epub 2022 Oct 7.
9
The Urinary Microbiome; Axis Crosstalk and Short-Chain Fatty Acid.泌尿微生物组;轴间串扰与短链脂肪酸
Diagnostics (Basel). 2022 Dec 10;12(12):3119. doi: 10.3390/diagnostics12123119.

本文引用的文献

1
Prostate diseases and microbiome in the prostate, gut, and urine.前列腺疾病以及前列腺、肠道和尿液中的微生物群。
Prostate Int. 2022 Jun;10(2):96-107. doi: 10.1016/j.prnil.2022.03.004. Epub 2022 Mar 29.
2
The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction.肠道微生物群、良性前列腺增生和勃起功能障碍之间的关系。
Int J Impot Res. 2023 Jun;35(4):350-355. doi: 10.1038/s41443-022-00569-1. Epub 2022 Apr 13.
3
Urobiome: An outlook on the metagenome of urological diseases.尿宏基因组学:泌尿系统疾病宏基因组展望。
Investig Clin Urol. 2021 Nov;62(6):611-622. doi: 10.4111/icu.20210312.
4
The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement.人类肠道微生物群的厚壁菌门与拟杆菌门的比例与前列腺增生有关。
Prostate. 2021 Dec;81(16):1287-1293. doi: 10.1002/pros.24223. Epub 2021 Sep 13.
5
Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.前列腺炎对良性前列腺增生发展和进展的影响:文献综述。
Int J Urol. 2021 Nov;28(11):1086-1092. doi: 10.1111/iju.14644. Epub 2021 Aug 2.
6
Urinary Microbiome: Yin and Yang of the Urinary Tract.尿微生物组:尿路的阴阳。
Front Cell Infect Microbiol. 2021 May 18;11:617002. doi: 10.3389/fcimb.2021.617002. eCollection 2021.
7
The impact of urine microbiota in patients with lower urinary tract symptoms.尿液微生物组对下尿路症状患者的影响。
Ann Clin Microbiol Antimicrob. 2021 Apr 15;20(1):23. doi: 10.1186/s12941-021-00428-9.
8
The Urinary Tract Microbiome in Male Genitourinary Diseases: Focusing on Benign Prostate Hyperplasia and Lower Urinary Tract Symptoms.男性生殖泌尿系统疾病中的尿道微生物群:聚焦于良性前列腺增生和下尿路症状
Int Neurourol J. 2021 Mar;25(1):3-11. doi: 10.5213/inj.2040174.087. Epub 2021 Jan 19.
9
Deciphering the Urinary Microbiota Repertoire by Culturomics Reveals Mostly Anaerobic Bacteria From the Gut.通过 culturomics 解析尿微生物群谱揭示肠道中大多为厌氧菌。
Front Microbiol. 2020 Oct 16;11:513305. doi: 10.3389/fmicb.2020.513305. eCollection 2020.
10
Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells.大肠杆菌是良性前列腺增生相关微生物群的常见组成部分,可诱导前列腺上皮细胞炎症和 DNA 损伤。
Prostate. 2020 Nov;80(15):1341-1352. doi: 10.1002/pros.24063. Epub 2020 Aug 24.

尿微生物群在良性前列腺增生/下尿路症状中的潜在作用

The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms.

作者信息

Yu Seong Hyeon, Jung Seung Il

机构信息

Chonnam National University Medical School, Gwangju 61469, Korea.

出版信息

Diagnostics (Basel). 2022 Aug 1;12(8):1862. doi: 10.3390/diagnostics12081862.

DOI:10.3390/diagnostics12081862
PMID:36010213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406308/
Abstract

Historically, urine in the urinary tract was considered "sterile" based primarily on culture-dependent methods of bacterial detection. Rapidly developing sequencing methods and analytical techniques have detected bacterial deoxyribonucleic acid and live bacteria in urine, improving our ability to understand the urinary tract microbiome. Recently, many studies have revealed evidence of a microbial presence in human urine in the absence of clinical infections. In women, fascinating evidence associates urinary tract microbiota with lower urinary tract symptoms (LUTS). However, the association between urinary tract microbiota and men with LUTS, particularly those with benign prostate hyperplasia (BPH), has not been established. In addition, the identification of the proinflammatory cytokines and pathogens responsible for the clinical progression of BPH is still underway. This review article aimed to address microbiome-related evidence for BPH. Further studies are required for a comprehensive understanding of the relationship between the urogenital microbiome and BPH pathogenesis to facilitate the development of preventive and therapeutic approaches for male LUTS.

摘要

从历史上看,基于主要依赖培养的细菌检测方法,泌尿道中的尿液被认为是“无菌的”。快速发展的测序方法和分析技术已在尿液中检测到细菌脱氧核糖核酸和活细菌,提高了我们对泌尿道微生物群的理解能力。最近,许多研究揭示了在无临床感染情况下人体尿液中存在微生物的证据。在女性中,有趣的证据将泌尿道微生物群与下尿路症状(LUTS)联系起来。然而,泌尿道微生物群与患有LUTS的男性,尤其是患有良性前列腺增生(BPH)的男性之间的关联尚未确立。此外,导致BPH临床进展的促炎细胞因子和病原体的鉴定仍在进行中。这篇综述文章旨在探讨与BPH相关的微生物群证据。需要进一步研究以全面了解泌尿生殖微生物群与BPH发病机制之间的关系,从而促进男性LUTS预防和治疗方法的发展。